Transfusion-related Epstein-Barr virus infection among stem cell transplant recipients: A retrospective cohort study in children

Transfusion

Volumn 52, Issue 12, 2012, Pages 2653-2663

  Trottier, Helen ^a,b,c,d   Buteau, Chantal ^a,b,c,d   Robitaille, Nancy ^a,b,c,d   Duval, Michel ^a,b,c,d   Tucci, Marisa ^a,b,c,d   Lacroix, Jacques ^a,b,c,d   Alfieri, Caroline ^a,b,c,d  

^a UNIVERSITY OF MONTREAL   (Canada)

^b Division of Infectious Diseases   (Canada)

^c Division of Hematology/Oncology   (Canada)

^d Department of Pediatrics   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; VIRUS ANTIBODY;

ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD TRANSFUSION; CHILD; CORRELATIONAL STUDY; CRYOPRECIPITATE; EPSTEIN BARR VIRUS INFECTION; ERYTHROCYTE CONCENTRATE; FEMALE; GRAFT RECIPIENT; GRANULOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SEROLOGY; SEROPREVALENCE; VIRUS LOAD;

ADOLESCENT; ANTIBODIES, VIRAL; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LEUKEMIA; MALE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84870998174     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03611.x     Document Type: Review

References (50)

1. Hema-Québec. Safety measures in place. [cited 2011 May 24]. Available from: URL: http://www.hema-quebec.qc.ca/comprendre/mesures-de- securite/securite-en-place.en.html
2. Canadian Blood Services. Safety and testing. [cited 2011 May 3]. Available from: URL: http://www.bloodservices.ca/CentreApps/Internet/UW-V502- MainEngine.nsf/page/Testing?OpenDocument
3. Macdonald N,. Transfusion and risk of infection in Canada: update 2005. Can J Infect Dis Med Microbiol 2005; 16: 161-5.
4. Chamberland ME, Alter HJ, Busch MP, Nemo G, Ricketts M,. Emerging infectious disease issues in blood safety. Emerg Infect Dis 2001; 7 Suppl: 552-3.
5. Strong DM, Katz L,. Blood-bank testing for infectious diseases: how safe is blood transfusion? Trends Mol Med 2002; 8: 355-8.
6. Vamvakas EC,. Is human herpesvirus-8 transmitted by transfusion? Transfus Med Rev 2010; 24: 1-14.
7. Karimi G, Samiei S, Hatami H, Gharehbaghian A, Vafaiyan V, Namini MT,. Detection of Chlamydia pneumoniae in peripheral blood mononuclear cells of healthy blood donors in Tehran Regional Educational Blood Transfusion Centre. Transfus Med 2010; 20: 237-43.
8. Trimble SR, Parker CS, Grant AM, Soucie JM, Reyes N,. Assessing emerging infectious threats to blood safety for the blood disorders community. Am J Prev Med 2010; 38 Suppl: S468-74.
9. Smith JM, Corey L, Healey PJ, Davis CL, McDonald RA,. Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients. Transplantation 2007; 83: 1423-8.
10. Aalto SM, Juvonen E, Tarkkanen J, Volin L, Haario H, Ruutu T, Hedman K,. Epstein-Barr viral load and disease prediction in a large cohort of allogeneic stem cell transplant recipients. Clin Infect Dis 2007; 45: 1305-9.
11. Allen U, Alfieri C, Preiksaitis J, Humar A, Moore D, Tapiero B, Tellier R, Green M, Davies D, Hébert D, Weitzman S, Petric M, Jacobson K,; Canadian PTLD Workshop Group-1999. Epstein-Barr virus infection in transplant recipients: summary of a workshop on surveillance, prevention and treatment. Can J Infect Dis 2002; 3: 89-99.
12. Ocheni S, Kroeger N, Zabelina T, Sobottka I, Ayuk F, Wolschke C, Muth A, Lellek H, Petersen L, Erttmann R, Kabisch H, Zander AR, Bacher U,. EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT. Bone Marrow Transplant 2008; 42: 181-6.
13. Higgins CD, Swerdlow AJ, Macsween KF, Harrison N, Williams H, McAulay K, Thomas R, Reid S, Conacher M, Britton K, Crawford DH,. A study of risk factors for acquisition of Epstein-Barr virus and its subtypes. J Infect Dis 2007; 195: 474-82.
14. Pariente M, Bartolome J, Lorente S, Crespo MD,. Age distribution of serological profiles of Epstein-Barr virus infection: review of results from a diagnostic laboratory. Enferm Infecc Microbiol Clin 2007; 25: 108-10.
15. Rocchi G, de Felici A, Ragona G, Heinz A,. Quantitative evaluation of Epstein-Barr virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N Engl J Med 1977; 296: 132-4.
16. Riddler SA, Breinig MC, McKnight JL,. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid organ transplant recipients. Blood 1994; 84: 972-84.
17. Hudnall SD, Chen T, Allison P, Tyring SK, Heath A,. Herpesvirus prevalence and viral load in healthy blood donors by quantitative real-time polymerase chain reaction. Transfusion 2008; 48: 1180-7.
18. Wagner HJ, Kluter H, Kruse A, Bucsky P, Hornef M, Kirchner H,. Determination of the number of Epstein-Barr virus genomes in whole blood and red cell concentrates. Transfus Med 1995; 5: 297-302.
19. Gerber P, Walsh JH, Rosenblum EN, Purcell RH,. Association of EB-virus infection with the post-perfusion syndrome. Lancet 1969; 1: 593-5.
20. Henle W, Henle G, Scriba M, Joyner CR, Harrison FS Jr, Von Essen R, Paloheimo J, Klemola E,. Antibody responses to the Epstein-Barr virus and cytomegaloviruses after open-heart and other surgery. N Engl J Med 1970; 282: 1068-74.
21. Carter JW, Edson RS, Kennedy CC,. Infectious mononucleosis in the older patient. Mayo Clin Proc 1978; 53: 146-50.
22. McMonigal K, Horwitz CA, Henle W, Henle G, Lawton J, Polesky H, Peterson L,. Post-perfusion syndrome due to Epstein-Barr virus. Report of two cases and review of the literature. Transfusion 1983; 23: 331-5.
23. Turner AR, McDonald RN, Cooper BA,. Transmission of infectious mononucleosis by transfusion of pre-illness plasma. Ann Int Med 1972; 77: 751-3.
24. Blacklow NR, Watson BK, Miller G, Jacobson BM,. Mononucleosis with heterophil antibodies and EB virus infection. Acquisition by an elderly patient in hospital. Am J Med 1971; 51: 549-52.
25. Henle W, Henle G,. Epstein-Barr virus and blood transfusion. In:, Dodd RY, Barker LF, editors. Infection, immunity and blood transfusion. Proceedings of the XVth Annual Scientific Sympoium of the American Red Cross. New York: Liss; 1985. p. 201.
26. Solem JH, Jörgensen W,. Accidentally transmitted infectious mononucleosis. Report of a case. Acta Med Scand 1969; 186: 433-7.
27. Kapsenberg JG, Langenhuysen MM, Nieweg HO, Deiss H,. Posttransfusion mononucleosis with heterophil antibodies. Simultaneous infection with cytomegalovirus and EB virus. Acta Med Scand 1970; 187: 79-82.
28. Tattevin P, Crémieux AC, Descamps D, Carbon C,. Transfusion-related infectious mononucleosis. Scand J Infect Dis 2002; 34: 777-8.
29. Alfieri C, Tanner J, Carpentier L, Perpête C, Savoie A, Paradis K, Delage G, Joncas J,. Epstein-Barr virus transmission from a blood donor to an organ transplant recipient with recovery of the same virus strain from the recipient's blood and oropharynx. Blood 1996; 87: 812-7.
30. Yao QY, Croom-Carter DS, Tierney RJ, Habeshaw G, Wilde JT, Hill FG, Conlon C, Rickinson AB,. Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohort. J Virol 1998; 72: 4352-63.
31. Murdock J, Morris TC, Alexander HD, McNamee P,. Red cell aplasia due to erythrovirus parvovirus B19 infection in a Jehovah's witness with post-transplant EBV-induced aggressive lymphoma: management considerations. Leuk Lymphoma 2002; 43: 211-3.
32. Dalle J, Duval M, Moghrabi A, Wagner E, Vachon MF, Barrette S, Bernstein M, Champagne J, David M, Demers J, Rousseau P, Winikoff R, Champagne MA,. Results of an unrelated transplant search strategy using partially HLA-mismatched cord-blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant 2004; 33: 605-11.
33. Tabor E,. The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1. Transfusion 1999; 39: 1160-8.
34. Hillyer CD, Silberstein LE, Ness PM, Anderson KC, Roback JD, editors. Blood banking and transfusion medicine-basic principles and practice. 2nd ed. Philadelphia (PA): Churchill Livingstone; 2007.
35. Weinberg A, Enomoto L, Li S, Shen D, Coll J, Shpall EJ,. Risk of transmission of herpesviruses through cord blood transplantation. Biol Blood Marrow Transplant 2005; 11: 35-8.
36. Breinig MK, Zitelli B, Starzl TE, Ho M,. Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis 1987; 156: 273-9.
37. Ho M, Jaffe R, Miller G, Breinig MK, Dummer JS, Makowka L, Atchison RW, Karrer F, Nalesnik MA, Starzl TE,. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestation in children. Transplantation 1988; 45: 719-27.
38. Chang RS, Blakenship W,. Spontaneous in vitro transformation of leukocytes from a neonate. Proc Soc Exp Biol Med 1973; 144: 337-9.
39. Haut PR, Kovarik P, Shaw PH, Walterhouse D, Jenson HB, Kletzel M,. Detection of EBV DNA in the cord blood donor for a patient developing Epstein-Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantation. Bone Marrow Transplant 2001; 27: 761-5.
40. Gibson BE, Todd A, Roberts I, Pamphilon D, Rodeck C, Bolton-Maggs P, Burbin G, Duguid J, Boulton F, Cohen H, Smith N, McClelland DB, Rowley M, Turner G,; British Commitee for Standards in Haematology Transfusion Task Force: Writing group. Transfusion guidelines for neonates and older children. Br J Haematol 2004; 124: 433-53.
41. Nichols WG, Price TH, Gooley T, Corey L, Boeckh M,. Transfusion- transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood 2003; 101: 4195-200.
42. Hillyer CD, Strauss RG, Luban NL,. Handbook of pediatric transfusion medicine. San Diago (CA): Academic; 2004.
43. Joncas JH, Russo P, Brochu P, Simard P, Brisebois J, Dubé J, Marton D, Leclerc JM, Hume H, Rivard GE,. Epstein-Barr virus polymorphic B-cell lymphoma associated with leukemia and with congenital immunodeficiencies. J Clin Oncol 1990; 8: 378-84.
44. Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E, Cohen JI,. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 1989; 321: 1080-5.
45. Hanto DW, Gajl-Peczalska KJ, Frizzera G, Arthur DC, Balfour HH Jr, McClain K, Simmons RL, Najarian JS,. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 1983; 198: 356-69.
46. Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, Durnam DM,. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 1988; 72: 520-9.
47. Cohen JI,. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine (Baltimore) 1991; 70: 137-60.
48. Curtis RE, Travis LB, Rowlings PA, Socié G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF Jr, Deeg HJ,. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94: 2208-16.
49. Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers ME, Martin PJ, Deeg HJ, Curtis RE,. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 4992-5001.
50. Cesaro S, Pegoraro A, Tridello G, Calore E, Pillon M, Varotto S, Abate D, Barzon L, Mengoli C, Carli M, Messina C,. A prospective study on modulation of immunosuppression for Epstein-Barr virus reactivation in pediatric patients who underwent unrelated hematopoietic stem-cell transplantation. Transplantation 2010; 89: 1533-40.